• Health & Medicine

COVID-19: “The really hard part is we know what needs to be done”

We caught up with a number of researchers about how COVID-19 has impacted their work, and what the next few months looks like for them. We caught up with a number of researchers about how COVID-19 has impacted their work, and what the next few months looks like for them.

7 July 2020

• Health & Medicine

Coronavirus and cancer – July updates

We’re monitoring the latest government and NHS health updates from across the UK. We’re monitoring the latest government and NHS health updates from across the UK.

7 July 2020

• Science & Technology
• Health & Medicine

News digest – naked mole-rats, junk food deals, ovarian cancer drug and glowing surgery dye

Our scientists have uncovered more about the naked mole-rat's resistance to cancer. Our scientists have uncovered more about the naked mole-rat's resistance to cancer.

4 July 2020

• Health & Medicine
• Science & Technology

COVID-19: “It could take months to build research up again”

Professor Richard Gilbertson talks about the impact of COVID-19 on research at the Cancer Research UK Cambridge Centre. Professor Richard Gilbertson talks about the impact of COVID-19 on research at the Cancer Research UK Cambridge Centre.

1 July 2020

• Science & Technology

Secrets of naked mole-rat cancer resistance unearthed

Naked mole-rats' exceptional resistance to cancer is thanks to unique conditions in their bodies that stop cancer cells multiplying, according to new research. Naked mole-rats' exceptional resistance to cancer is thanks to unique conditions in their bodies that stop cancer cells multiplying, according to new research.

1 July 2020

• Health & Medicine

Scotland's lifeline cancer trials must be restarted urgently

Cancer Research UK’s calls backed by eminent Edinburgh scientist who says the COVID-19 halt to clinical trials has taken away hope for some patients. Cancer Research UK’s calls backed by eminent Edinburgh scientist who says the COVID-19 halt to clinical trials has taken away hope for some patients.

29 June 2020

• Science & Technology

News digest – targeted drug approval, microbubble 'warheads' and prostate cancer treatment

Researchers are using ultrasound to destroy cancer cells by detonating microbubbles like "targeted warheads." Researchers are using ultrasound to destroy cancer cells by detonating microbubbles like "targeted warheads."

27 June 2020

• Personal Stories

Coronavirus reports - Part 6: “As a Black man with advanced prostate cancer, who wouldn’t be worried?”

Earlier this month, Public Health England published a long-awaited report confirming that COVID-19 is disproportionately affecting Black, Asian and minority ethnic communities. We spoke to Anisha and Alfred about the findings. Earlier this month, Public Health England published a long-awaited report confirming that COVID-19 is disproportionately affecting Black, Asian and minority ethnic communities. We spoke to Anisha and Alfred about the findings.

26 June 2020

• Health & Medicine

Prostate cancer hormone therapy not recommended for NHS in England

A hormone therapy has been rejected for some adults with newly-diagnosed, advanced prostate cancer. A hormone therapy has been rejected for some adults with newly-diagnosed, advanced prostate cancer.

26 June 2020

• Health & Medicine

Targeted drug improves survival for children with non-Hodgkin lymphoma

New clinical trial results show that adding rituximab to standard chemotherapy could improve survival for some children with non-Hodgkin lymphoma. New clinical trial results show that adding rituximab to standard chemotherapy could improve survival for some children with non-Hodgkin lymphoma.

25 June 2020

• For Researchers

Lockdown reflections: Survey reveals researchers’ experiences

We share the findings of our survey about the experiences of cancer researchers during the COVID-19 pandemic. We share the findings of our survey about the experiences of cancer researchers during the COVID-19 pandemic.

25 June 2020

• Policy & Insight

Opinion: ‘UK cancer research could be set back years by COVID-19. We must act now’

Because of COVID-19 and the devastating impact it’s had on our income, we could be forced to cut £150 million per year from our research funding.  Because of COVID-19 and the devastating impact it’s had on our income, we could be forced to cut £150 million per year from our research funding. 

24 June 2020